title: Extensive fibromuscular dysplasia in a patient with Parkinson disease.
abstract: The cause of fibromuscular dysplasia is not known. Ergot derivatives have been reported as a potential causative agent. The anti-Parkinson medication pergolide is an ergot derivative, but an association between fibromuscular dysplasia and this drug has not been previously reported.
authors.affiliation: Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
authors.forename: Thomas H
authors.initials: TH
authors.lastname: Wang
authors.forename: Matthew
authors.initials: M
authors.lastname: Mauro
authors.forename: J Charles
authors.initials: JC
authors.lastname: Jennette
authors.forename: Stephan
authors.initials: S
authors.lastname: Moll
mesh_terms: D005260:Female; D005352:Fibromuscular Dysplasia / Q000139:chemically induced / Q000473:pathology*; D006801:Humans; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy / Q000473:pathology*; D010479:Pergolide / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D010479:Pergolide